B/BE/22/BVW6 - Fiche d'information destinée au public (préparée par le notifiant)

File: 
PDF icon bbe22bvw6_pub_fr.pdf
Trial reference: 
A phase 3, Multinational, Randomized, Double-Blind, Placebo-Controlled Systemic Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of SRP-9001 in Non-Ambulatory and Ambulatory Subjects With Duchenne Muscular Dystrophy (ENVISION)
Doc type: 
Information for the public